MedPath

Levora

LEVORA 0.15/30-28 (levonorgestrel 0.15 mg and ethinyl estradiol 0.03 mg tablets)

Approved
Approval ID

0f2abab7-6dbe-4b18-b001-002b668eb370

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 7, 2023

Manufacturers
FDA

RPK Pharmaceuticals, Inc.

DUNS: 147096275

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

levonorgestrel and ethinyl estradiol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code53002-1565
Application NumberANDA073594
Product Classification
M
Marketing Category
C73584
G
Generic Name
levonorgestrel and ethinyl estradiol
Product Specifications
Effective DateMarch 3, 2022
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Levora - FDA Drug Approval Details